The prion hypothesis: from biological anomaly to basic regulatory mechanism (original) (raw)

• Prusiner, S. B. Novel proteinaceous infectious particles cause scrapie. Science 216, 136–144 (1982).
  Article CAS PubMed Google Scholar
• Prusiner, S. B. Prions. Proc. Natl Acad. Sci. USA 95, 13363–13383 (1998).
  CAS PubMed PubMed Central Google Scholar
• Griffith, J. S. Self-replication and scrapie. Nature 215, 1043–1044 (1967).
  CAS PubMed Google Scholar
• Wickner, R. B., Edskes, H. K., Shewmaker, F. & Nakayashiki, T. Prions of fungi: inherited structures and biological roles. Nature Rev. Microbiol. 5, 611–618 (2007).
  CAS Google Scholar
• Collinge, J. & Clarke, A. R. A general model of prion strains and their pathogenicity. Science 318, 930–936 (2007).
  CAS PubMed Google Scholar
• Nemecek, J., Nakayashiki, T. & Wickner, R. B. A prion of yeast metacaspase homolog (Mca1p) detected by a genetic screen. Proc. Natl Acad. Sci. USA 106, 1892–1896 (2009).
  CAS PubMed PubMed Central Google Scholar
• Wickner, R. B. [_URE3_] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264, 566–569 (1994). The first experimental proof that a non-Mendelian element (in this case [ URE3 ]) in yeast can be explained by the 'protein only' or prion hypothesis.
  CAS PubMed Google Scholar
• Michelitsch, M. D. & Weissman, J. S. A census of glutamine/asparagine-rich regions: implications for their conserved function and the prediction of novel prions. Proc. Natl Acad. Sci. USA 97, 11910–11915 (2000).
  Google Scholar
• Alberti, S., Halfmann, R., King, O., Kapila, A. & Lindquist, S. A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 137, 146–158 (2009). A comprehensive study that reveals the diversity of potential prions in yeast and provides direct experimental proof for [ MOT3+], the prion form of the transcriptional co-repressor Mot3.
  CAS PubMed PubMed Central Google Scholar
• Cox, B. Ψ, a cytoplasmic suppressor of super-suppression in yeast. Heredity 20, 505–521 (1965).
  Google Scholar
• Culbertson, M. R., Charnas, L., Johnson, M. T. & Fink, G. R. Frameshifts and frameshift suppressors in Saccharomyces cerevisiae. Genetics 86, 745–764 (1977).
  CAS PubMed PubMed Central Google Scholar
• Patino, M. M., Liu, J. J., Glover, J. R. & Lindquist, S. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 273, 622–626 (1996).
  CAS PubMed Google Scholar
• Paushkin, S. V., Kushnirov, V. V., Smirnov, V. N. & Ter-Avanesyan, M. D. Propagation of the yeast prion-like [PSI+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J. 15, 3127–3134 (1996).
  CAS PubMed PubMed Central Google Scholar
• Chen, B., Newnam, G. P. & Chernoff, Y. O. Prion species barrier between the closely related yeast proteins is detected despite coaggregation. Proc. Natl Acad. Sci. USA 104, 2791–2796 (2007). Using the [ PSI+] yeast prion system, the authors show that the barrier to interspecies prion transmission occurs at the point of conformational replication rather than by the binding of two different conformers.
  CAS PubMed PubMed Central Google Scholar
• Eaglestone, S. S., Cox, B. S. & Tuite, M. F. Translation termination efficiency can be regulated in Saccharomyces cerevisiae by environmental stress through a prion-mediated mechanism. EMBO J. 18, 1974–1981 (1999).
  CAS PubMed PubMed Central Google Scholar
• True, H. L., Berlin, I. & Lindquist, S. L. Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits. Nature 431, 184–187 (2004).
  CAS PubMed Google Scholar
• True, H. L. & Lindquist, S. L. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 407, 477–483 (2000). An analysis of a range of phenotypes that differentiate [ PSI+] from [ psi − ] cells. The authors propose that the [ PSI+] prion provides the means to uncover hidden genetic variation and produce new heritable phenotypes.
• Williams, I., Richardson, J., Starkey, A. & Stansfield, I. Genome-wide prediction of stop codon readthrough during translation in the yeast Saccharomyces cerevisiae. Nucleic Acids Res. 32, 6605–6616 (2004).
  CAS PubMed PubMed Central Google Scholar
• Wilson, M. A., Meaux, S., Parker, R. & van Hoof, A. Genetic interactions between [PSI+] and nonstop mRNA decay affect phenotypic variation. Proc. Natl Acad. Sci. USA 102, 10244–10249 (2005).
  CAS PubMed PubMed Central Google Scholar
• Palanimurugan, R., Scheel, H., Hofmann, K. & Dohmen, R. J. Polyamines regulate their synthesis by inducing expression and blocking degradation of ODC antizyme. EMBO J. 23, 4857–4867 (2004).
  CAS PubMed PubMed Central Google Scholar
• Namy, O. et al. Epigenetic control of polyamines by the prion [PSI+]. Nature Cell Biol. 10, 1069–1075 (2008). The authors show that [ PSI+] enhances the synthesis of antizyme, a regulator of polyamine synthesis, through a −1 frameshift event. This in turn leads to the modulation of the levels of polyamines in the yeast cell that can lead to a range of phenotypes, including some of those described in reference 17.
  CAS PubMed Google Scholar
• Namy, O., Duchateau-Nguyen, G. & Rousset, J. P. Translational readthrough of the PDE2 stop codon modulates cAMP levels in Saccharomyces cerevisiae. Mol. Microbiol. 43, 641–652 (2002).
  CAS PubMed Google Scholar
• Du, Z., Park, K. W., Yu, H., Fan, Q. & Li, L. Newly identified prion linked to the chromatin-remodeling factor Swi1 in Saccharomyces cerevisiae. Nature Genet. 40, 460–465 (2008). This article describes a yeast prion that is formed by a key chromatin remodelling factor and thus reveals a possible link between global transcriptional regulation and the ability of Swi1 to undergo conformational conversion.
  CAS PubMed Google Scholar
• Patel, B. K., Gavin-Smyth, J. & Liebman, S. W. The yeast global transcriptional co-repressor protein Cyc8 can propagate as a prion. Nature Cell Biol. 11, 344–349 (2009).
  CAS PubMed Google Scholar
• Hongay, C., Jia, N., Bard, M. & Winston, F. Mot3 is a transcriptional repressor of ergosterol biosynthetic genes and is required for normal vacuolar function in Saccharomyces cerevisiae. EMBO J. 21, 4114–4124 (2002).
  CAS PubMed PubMed Central Google Scholar
• Lempiäinen, H. & Shore, D. Growth control and ribosome biogenesis. Curr. Opin. Cell Biol. 21, 855–863 (2009).
  PubMed Google Scholar
• Courchesne, W. E. & Magasanik, B. Regulation of nitrogen assimilation in Saccharomyces cerevisiae: roles of the URE2 and GLN3 genes. J. Bacteriol. 170, 708–713 (1988).
  CAS PubMed PubMed Central Google Scholar
• Cunningham, T. S., Andhare, R. & Cooper, T. G. Nitrogen catabolite repression of DAL80 expression depends on the relative levels of Gat1p and Ure2p production in Saccharomyces cerevisiae. J. Biol. Chem. 275, 14408–14414 (2000).
  CAS PubMed Google Scholar
• Rai, R., Tate, J. J. & Cooper, T. G. Ure2, a prion precursor with homology to glutathione _S_-transferase, protects Saccharomyces cerevisiae cells from heavy metal ion and oxidant toxicity. J. Biol. Chem. 278, 12826–12833 (2003).
  CAS PubMed Google Scholar
• Rogoza, T. et al. Non-Mendelian determinant [ISP+] in yeast is a nuclear-residing prion form of the global transcriptional regulator Sfp1. Proc. Natl Acad. Sci. USA 107, 10573–10577 (2010).
  CAS PubMed PubMed Central Google Scholar
• Saupe, S. J. A short history of small s: a prion of the fungus Podospora anserina. Prion 1, 110–115 (2007).
  PubMed PubMed Central Google Scholar
• Coustou, V., Deleu, C., Saupe, S. & Begueret, J. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc. Natl Acad. Sci. USA 94, 9773–9778 (1997).
  CAS PubMed PubMed Central Google Scholar
• Paoletti, M. & Saupe, S. J. Fungal incompatibility: evolutionary origin in pathogen defense? Bioessays 31, 1201–1210 (2009).
  CAS PubMed Google Scholar
• Greenwald, J. et al. The mechanism of prion inhibition by HET-S. Mol. Cell 38, 889–899 (2010). The authors show that the inhibition of the fibrillization of P. anserina HET-s by the closely related HET-S protein is not encoded by the structural differences per se . Instead, it reflects an effect on the stability and oligomerization properties of the mixed aggregates formed between the two proteins.
  CAS PubMed PubMed Central Google Scholar
• Sondheimer, N. & Lindquist, S. Rnq1: an epigenetic modifier of protein function in yeast. Mol. Cell 5, 163–172 (2000).
  CAS PubMed Google Scholar
• Derkatch, I. L., Bradley, M. E., Hong, J. Y. & Liebman, S. W. Prions affect the appearance of other prions: the story of [PIN+]. Cell 106, 171–182 (2001).
  CAS PubMed Google Scholar
• Osherovich, L. Z. & Weissman, J. S. Multiple Gln/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI+] prion. Cell 106, 183–194 (2001).
  CAS PubMed Google Scholar
• Resende, C. G., Outeiro, T. F., Sands, L., Lindquist, S. & Tuite, M. F. Prion protein gene polymorphisms in Saccharomyces cerevisiae. Mol. Microbiol. 49, 1005–1017 (2003).
  CAS PubMed Google Scholar
• Nakayashiki, T., Kurtzman, C. P., Edskes, H. K. & Wickner, R. B. Yeast prions [_URE3_] and [PSI+] are diseases. Proc. Natl Acad. Sci. USA 102, 10575–10580 (2005). This paper opens up the debate about the impact of yeast prions on the host and argues that because neither the [ URE3 ] nor [ PSI+] prions are present in 70 different wild strains, they must have a negative effect on the host.
  CAS PubMed PubMed Central Google Scholar
• Derkatch, I. L. et al. Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. Proc. Natl Acad. Sci. USA 101, 12934–12939 (2004).
  CAS PubMed PubMed Central Google Scholar
• Derkatch, I. L. et al. Dependence and independence of [PSI+] and [PIN+]: a two-prion system in yeast? EMBO J. 19, 1942–1952 (2000).
  CAS PubMed PubMed Central Google Scholar
• Dalstra, H. J., Swart, K., Debets, A. J., Saupe, S. J. & Hoekstra, R. F. Sexual transmission of the [Het-S] prion leads to meiotic drive in Podospora anserina. Proc. Natl Acad. Sci. USA 100, 6616–6621 (2003).
  CAS PubMed PubMed Central Google Scholar
• Ter-Avanesyan, M. D. et al. Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol. Microbiol. 7, 683–692 (1993).
  CAS PubMed Google Scholar
• Griswold, C. K. & Masel, J. Complex adaptations can drive the evolution of the capacitor [_PSI_], even with realistic rates of yeast sex. PLoS Genet. 5, e1000517 (2009).
  PubMed PubMed Central Google Scholar
• Joseph, S. B. & Kirkpatrick, M. Effects of the [PSI+] prion on rates of adaptation in yeast. J. Evol. Biol. 21, 773–780 (2008).
  CAS PubMed Google Scholar
• Brundin, P., Melki, R. & Kopito, R. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nature Rev. Mol. Cell Biol. 11, 301–307 (2010).
  CAS Google Scholar
• Meyer-Luehmann, M. et al. Exogenous induction of cerebral β-amyloidogenesis is governed by agent and host. Science 313, 1781–1784 (2006).
  CAS PubMed Google Scholar
• Ren, P. H. et al. Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nature Cell Biol. 11, 219–225 (2009).
  CAS PubMed Google Scholar
• Li, J. Y. et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nature Med. 14, 501–503 (2008).
  CAS PubMed Google Scholar
• Aguzzi, A. Cell biology: Beyond the prion principle. Nature 459, 924–925 (2009).
  CAS PubMed Google Scholar
• Glabe, C. G. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol. Aging 27, 570–575 (2006).
  CAS PubMed Google Scholar
• Barnhart, M. M. & Chapman, M. R. Curli biogenesis and function. Annu. Rev. Microbiol. 60, 131–147 (2006).
  CAS PubMed PubMed Central Google Scholar
• Si, K., Choi, Y. B., White-Grindley, E., Majumdar, A. & Kandel, E. R. Aplysia CPEB can form prion-like multimers in sensory neurons that contribute to long-term facilitation. Cell 140, 421–435 (2010).
  CAS PubMed Google Scholar
• Fowler, D. M. et al. Functional amyloid formation within mammalian tissue. PLoS Biol. 4, e6 (2006).
  PubMed Google Scholar
• Berson, J. F. et al. Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident glycoprotein to initiate melanosome biogenesis. J. Cell Biol. 161, 521–533 (2003).
  CAS PubMed PubMed Central Google Scholar
• Maji, S. K. et al. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 325, 328–332 (2009).
  CAS PubMed PubMed Central Google Scholar
• Aguzzi, A., Baumann, F. & Bremer, J. The prion's elusive reason for being. Annu. Rev. Neurosci. 31, 439–477 (2008).
  CAS PubMed Google Scholar
• Mallucci, G. R. et al. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 53, 325–335 (2007).
  CAS PubMed Google Scholar
• White, M. D. et al. Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc. Natl Acad. Sci. USA 105, 10238–10243 (2008).
  CAS PubMed PubMed Central Google Scholar
• Steele, A. D., Lindquist, S. & Aguzzi, A. The prion protein knockout mouse: a phenotype under challenge. Prion 1, 83–93 (2007).
  PubMed PubMed Central Google Scholar
• Isaacs, J. D., Jackson, G. S. & Altmann, D. M. The role of the cellular prion protein in the immune system. Clin. Exp. Immunol. 146, 1–8 (2006).
  CAS PubMed PubMed Central Google Scholar
• Wilson, D. A. & Nixon, R. A. Sniffing out a function for prion proteins. Nature Neurosci. 12, 7–8 (2009).
  CAS PubMed Google Scholar
• Malaga-Trillo, E. et al. Regulation of embryonic cell adhesion by the prion protein. PLoS Biol. 7, e55 (2009).
  PubMed Google Scholar
• Bremer, J. et al. Axonal prion protein is required for peripheral myelin maintenance. Nature Neurosci. 13, 310–318 (2010).
  CAS PubMed Google Scholar
• Westergard, L., Christensen, H. M. & Harris, D. A. The cellular prion protein (PrPC): its physiological function and role in disease. Biochim. Biophys. Acta 1772, 629–644 (2007).
  CAS PubMed PubMed Central Google Scholar
• Shmerling, D. et al. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93, 203–214 (1998).
  CAS PubMed Google Scholar
• Baumann, F. et al. Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J. 26, 538–547 (2007).
  CAS PubMed PubMed Central Google Scholar
• Mallucci, G. et al. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302, 871–874 (2003).
  CAS PubMed Google Scholar
• Brandner, S. et al. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339–343 (1996).
  CAS PubMed Google Scholar
• Chesebro, B. et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308, 1435–1439 (2005).
  CAS PubMed Google Scholar
• Nicoll, A. J. & Collinge, J. Preventing prion pathogenicity by targeting the cellular prion protein. Infect. Disord. Drug Targets 9, 48–57 (2009).
  CAS PubMed Google Scholar
• Radford, H. E. & Mallucci, G. R. The role of GPI-anchored PRPC in mediating the neurotoxic effect of scrapie prions in neurons. Curr. Issues Mol. Biol. 12, 119–128 (2009).
  PubMed Google Scholar
• Büeler, H. et al. High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol. Med. 1, 19–30 (1994).
  PubMed Google Scholar
• Masel, J., Jansen, V. A. & Nowak, M. A. Quantifying the kinetic parameters of prion replication. Biophys. Chem. 77, 139–152 (1999).
  CAS PubMed Google Scholar
• Haslberger, T., Bukau, B. & Mogk, A. Towards a unifying mechanism for ClpB/Hsp104-mediated protein disaggregation and prion propagation. Biochem. Cell Biol. 88, 63–75 (2010).
  CAS PubMed Google Scholar
• Jones, G. W. & Tuite, M. F. Chaperoning prions: the cellular machinery for propagating an infectious protein? Bioessays 27, 823–832 (2005).
  CAS PubMed Google Scholar
• Prusiner, S. et al. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63, 673–686 (1990).
  CAS PubMed Google Scholar
• Manson, J. C., Clarke, A. R., McBride, P. A., McConnell, I. & Hope, J. PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 3, 331–340 (1994).
  CAS PubMed Google Scholar
• Laurent, M. Bistability and the species barrier in prion diseases: stepping across the threshold or not. Biophys. Chem. 72, 211–222 (1998).
  CAS PubMed Google Scholar
• Sindi, S. S. & Serio, T. R. Prion dynamics and the quest for the genetic determinant in protein-only inheritance. Curr. Opin. Microbiol. 12, 623–630 (2009).
  CAS PubMed PubMed Central Google Scholar
• Legname, G. et al. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc. Natl Acad. Sci. USA 103, 19105–19110 (2006).
  CAS PubMed PubMed Central Google Scholar
• Tanaka, M., Collins, S. R., Toyama, B. H. & Weissman, J. S. The physical basis of how prion conformations determine strain phenotypes. Nature 442, 585–589 (2006).
  CAS PubMed Google Scholar
• Kimberlin, R. H. & Walker, C. A. Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture. J. Gen. Virol. 39, 487–496 (1978).
  CAS PubMed Google Scholar
• Marsh, R. F. & Hanson, R. P. in Slow Transmissible Diseases of the Nervous System (eds Prusiner, S. B. & Hadlow, W. J.) 451–460 (Academy Press, New York, 1979).
  Google Scholar
• Dickinson, A. G. in Slow Virus Diseases of Animals and Man (ed. Kimberlin, R. H.) 209–241 (North-Holland Publishing Company, Amsterdam, 1976).
  Google Scholar
• Derkatch, I. L., Bradley, M. E., Zhou, P. & Liebman, S. W. The PNM2 mutation in the prion protein domain of SUP35 has distinct effects on different variants of the [PSI+] prion in yeast. Curr. Genet. 35, 59–67 (1999).
  CAS PubMed Google Scholar
• Ghaemmaghami, S. et al. Continuous quinacrine treatment results in the formation of drug-resistant prions. PLoS Pathog. 5, e1000673 (2009). Quinacrine treatment induces the loss of some prion strains while promoting the amplification of others.
  PubMed PubMed Central Google Scholar
• Manuelidis, L., Fritch, W. & Xi, Y. G. Evolution of a strain of CJD that induces BSE-like plaques. Science 277, 94–98 (1997).
  CAS PubMed Google Scholar
• Li, J., Browning, S., Mahal, S. P., Oelschlegel, A. M. & Weissmann, C. Darwinian evolution of prions in cell culture. Science 327, 869–872 (2010). The frequency of prion strain mutations can be influenced by selective pressures, including host identity and exposure to chemical treatments.
  CAS PubMed Google Scholar
• Bruce, M. E. Scrapie strain variation and mutation. Br. Med. Bull. 49, 822–838 (1993).
  CAS PubMed Google Scholar
• Angers, R. C. et al. Prion strain mutation determined by prion protein conformational compatibility and primary structure. Science 328, 1154–1158 (2010). The frequency of prion strain mutation in chronic wasting disease has been linked to a change in PrP sequence that does not seem to alter the conformation of the prion form.
  CAS PubMed PubMed Central Google Scholar
• Bessen, R. A. & Marsh, R. F. Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J. Gen. Virol. 73, 329–334 (1992).
  PubMed Google Scholar
• Dickinson, A. G. & Outram, G. W. in Virus Nonconventionnels et Affections du Systeme Nerveux Central (eds Court, L. A. & Cathala, F.) 3–16 (Masson, Paris, 1983).
  Google Scholar
• Parchi, P. et al. Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol. 118, 659–671 (2009).
  CAS PubMed PubMed Central Google Scholar
• Cali, I. et al. Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 132, 2643–2658 (2009).
  PubMed PubMed Central Google Scholar
• Bruce, M., Fraser, H., McBride, P., Scott, J. & Dickinson, A. in Prion Diseases of Humans and Animals (eds Prusiner, S., Collinge, J., Powell, J. & Anderton, B.) 497–508 (Ellis Horwood, New York, 1992).
  Google Scholar
• Bartz, J. C., Bessen, R. A., McKenzie, D., Marsh, R. F. & Aiken, J. M. Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy. J. Virol. 74, 5542–5547 (2000).
  CAS PubMed PubMed Central Google Scholar
• Dickinson, A. G. et al. Extraneural competition between different scrapie agents leading to loss of infectivity. Nature 253, 556 (1975).
  CAS PubMed Google Scholar
• Dickinson, A. G., Fraser, H., Meikle, V. M. & Outram, G. W. Competition between different scrapie agents in mice. Nature New Biol. 237, 244–245 (1972).
  CAS PubMed Google Scholar
• Dickinson, A. G. & Outram, G. W. in Slow Transmissible Diseases of The Nervous System (eds Prusiner, S. B. & Hadlow, W. J.) 13–31 (Academic Press, New York, 1979).
  Google Scholar
• Shikiya, R. A., Ayers, J. I., Schutt, C. R., Kincaid, A. E. & Bartz, J. C. Coinfecting prion strains compete for a limiting cellular resource. J. Virol. 84, 5706–5714 (2010).
  CAS PubMed PubMed Central Google Scholar
• Bradley, M. E., Edskes, H. K., Hong, J. Y., Wickner, R. B. & Liebman, S. W. Interactions among prions and prion “strains” in yeast. Proc. Natl Acad. Sci. USA 99 (Suppl. 4), 16392–16399 (2002).
  CAS PubMed PubMed Central Google Scholar
• Morales, R., Abid, K. & Soto, C. The prion strain phenomenon: molecular basis and unprecedented features. Biochim. Biophys. Acta 1772, 681–691 (2007).
  CAS PubMed Google Scholar
• Goldfarb, L. et al. Patients wth Creutzfeldt-Jakob disease and kuru lack the mutation in the PRIP gene found in Gerstmann-Sträussler syndrome, but they show a different double-allele mutation in the same gene. Am. J. Hum. Genet. 45, A189 (1989).
  Google Scholar
• Owen, F., Poulter, M., Collinge, J. & Crow, T. J. Codon 129 changes in the prion protein gene in Caucasians. Am. J. Hum. Genet. 46, 1215–1216 (1990).
  CAS PubMed PubMed Central Google Scholar
• Liemann, S. & Glockshuber, R. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 38, 3258–3267 (1999).
  CAS PubMed Google Scholar
• Hosszu, L. L. et al. The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPC. J. Biol. Chem. 279, 28515–28521 (2004).
  CAS PubMed Google Scholar
• Apetri, A. C., Vanik, D. L. & Surewicz, W. K. Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90–231. Biochemistry 44, 15880–15888 (2005).
  CAS PubMed Google Scholar
• Baskakov, I. V., Legname, G., Baldwin, M. A., Prusiner, S. B. & Cohen, F. E. Pathway complexity of prion protein assembly into amyloid. J. Biol. Chem. 277, 21140–21148 (2002).
  CAS PubMed Google Scholar
• Come, J. & Lansbury, P. Predisposition of prion protein homozygotes to Creutzfeldt-Jakob disease can be explained by a nucleation-dependent polymerization mechanism. J. Am. Chem. Soc. 116, 4109–4110 (1994).
  CAS Google Scholar
• Tahiri-Alaoui, A., Gill, A. C., Disterer, P. & James, W. Methionine 129 variant of human prion protein oligomerizes more rapidly than the valine 129 variant: implications for disease susceptibility to Creutzfeldt-Jakob disease. J. Biol. Chem. 279, 31390–31397 (2004).
  CAS PubMed Google Scholar
• Tahiri-Alaoui, A., Sim, V. L., Caughey, B. & James, W. Molecular heterosis of prion protein β-oligomers. A potential mechanism of human resistance to disease. J. Biol. Chem. 281, 34171–34178 (2006).
  CAS PubMed Google Scholar
• Jeong, B. H. et al. Association of sporadic Creutzfeldt-Jakob disease with homozygous genotypes at PRNP codons 129 and 219 in the Korean population. Neurogenetics 6, 229–232 (2005).
  CAS PubMed Google Scholar
• Westaway, D. et al. Distinct prion proteins in short and long scrapie incubation period mice. Cell 51, 651–662 (1987).
  CAS PubMed Google Scholar
• Dickinson, A. G., Meikle, V. M. & Fraser, H. Identification of a gene which controls the incubation period of some strains of scrapie agent in mice. J. Comp. Pathol. 78, 293–299 (1968).
  CAS PubMed Google Scholar
• Foster, J. D. & Dickinson, A. G. The unusual properties of CH1641, a sheep-passaged isolate of scrapie. Vet. Rec. 123, 5–8 (1988).
  CAS PubMed Google Scholar
• Goldmann, W., Hunter, N., Smith, G., Foster, J. & Hope, J. PrP genotype and agent effects in scrapie: change in allelic interaction with different isolates of agent in sheep, a natural host of scrapie. J. Gen. Virol. 75, 989–995 (1994).
  CAS PubMed Google Scholar
• Gordon, W. ARS91–53: Report of Scrapie Seminar, 53–68 (US Department of Agriculture, 1964).
• Shibuya, S., Higuchi, J., Shin, R. W., Tateishi, J. & Kitamoto, T. Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 43, 826–828 (1998).
  CAS PubMed Google Scholar
• Westaway, D. et al. Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie. Genes Dev. 8, 959–969 (1994).
  CAS PubMed Google Scholar
• Kaneko, K. et al. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc. Natl Acad. Sci. USA 94, 10069–10074 (1997).
  CAS PubMed PubMed Central Google Scholar
• Perrier, V. et al. Dominant-negative inhibition of prion replication in transgenic mice. Proc. Natl Acad. Sci. USA 99, 13079–13084 (2002).
  CAS PubMed PubMed Central Google Scholar
• Geoghegan, J. C,. Miller, M. B,. Kwak, A. H,. Harris, B. T. & Supattapone, S. Trans- dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor. PLoS Pathog. 5, e1000535 (2009). Using PrP purified from mammalian cells and the protein misfolding cyclic amplification approach, the authors show that dominant-negative inhibition of prion propagation by a PrP mutant can be recapitulated in vitro in the absence of trans factors.
  PubMed PubMed Central Google Scholar
• Lee, C. I., Yang, Q., Perrier, V. & Baskakov, I. V. The dominant-negative effect of the Q218K variant of the prion protein does not require protein X. Protein Sci. 16, 2166–2173 (2007). Using recombinant protein purified from bacteria, the authors show that the Gln218Lys variant of PrP interferes with amyloid formation by wild-type PrP in vitro , and their studies suggest that the inhibition occurs not by an effect on binding but rather by a effect on conformational conversion.
  CAS PubMed PubMed Central Google Scholar
• Masel, J. & Jansen, V. A. Designing drugs to stop the formation of prion aggregates and other amyloids. Biophys. Chem. 88, 247–259 (2000).
  Google Scholar
• DePace, A. H., Santoso, A., Hillner, P. & Weissman, J. S. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93, 1241–1252 (1998).
  CAS PubMed Google Scholar
• Young, C. & Cox, B. Extrachromosomal elements in a super-suppression system of yeast I. A nuclear gene controlling the inheritance of the extrachromosomal elements. Heredity 26, 413–422 (1971).
  Google Scholar
• Doel, S. M., McCready, S. J., Nierras, C. R. & Cox, B. S. The dominant _PNM2_− mutation which eliminates the Ψ factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. Genetics 137, 659–670 (1994).
  CAS PubMed PubMed Central Google Scholar
• King, C. Y. Supporting the structural basis of prion strains: induction and identification of [_PSI_] variants. J. Mol. Biol. 307, 1247–1260 (2001).
  CAS PubMed Google Scholar
• Kochneva-Pervukhova, N. V. et al. Mechanism of inhibition of Ψ+ prion determinant propagation by a mutation of the N-terminus of the yeast Sup35 protein. EMBO J. 17, 5805–5810 (1998).
  CAS PubMed PubMed Central Google Scholar
• Osherovich, L. Z., Cox, B. S., Tuite, M. F. & Weissman, J. S. Dissection and design of yeast prions. PLoS Biol. 2, e86 (2004).
  PubMed PubMed Central Google Scholar
• Zlotnik, I. & Rennie, J. C. Experimental transmission of mouse passaged scrapie to goats, sheep, rats and hamsters. J. Comp. Pathol. 75, 147–157 (1965).
  CAS PubMed Google Scholar
• Pattison, I. in NINDB Monograph, No.2: Slow, Latent, and Temperate Virus Infections (eds Gajdusek D. C., Gibbs C. J. Jr & Alpers M. P.)249–257 (US National Institutes of Health, Bethesda, Maryland, 1965).
  Google Scholar
• Collinge, J., Sidle, K. C., Meads, J., Ironside, J. & Hill, A. F. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383, 685–690 (1996).
  CAS PubMed Google Scholar
• Bruce, M. E. et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389, 498–501 (1997).
  CAS PubMed Google Scholar
• Marsh, R. F., Burger, D., Eckroade, R., Zu Rhein, G. M. & Hanson, R. P. A preliminary report on the experimental host range of the transmissible mink encephalopathy agent. J. Infect. Dis. 120, 713–719 (1969).
  CAS PubMed Google Scholar
• Hill, A. F. et al. Species-barrier-independent prion replication in apparently resistant species. Proc. Natl Acad. Sci. USA 97, 10248–10253 (2000).
  CAS PubMed PubMed Central Google Scholar
• Race, R. & Chesebro, B. Scrapie infectivity found in resistant species. Nature 392, 770 (1998).
  CAS PubMed Google Scholar
• Dickinson, A. G., Fraser, H. & Outram, G. W. Scrapie incubation time can exceed natural lifespan. Nature 256, 732–733 (1975).
  CAS PubMed Google Scholar
• Windl, O. et al. Breaking an absolute species barrier: transgenic mice expressing the mink PrP gene are susceptible to transmissible mink encephalopathy. J. Virol. 79, 14971–14975 (2005).
  CAS PubMed PubMed Central Google Scholar
• Sigurdson, C. J. et al. A molecular switch controls interspecies prion disease transmission in mice. J. Clin. Invest. 120, 2590–2599 (2010). The authors show that the barrier to interspecies prion transmission may be the structure of a loop in the PrP protein.
  CAS PubMed PubMed Central Google Scholar
• Chien, P., Weissman, J. S. & DePace, A. H. Emerging principles of conformation-based prion inheritance. Annu. Rev. Biochem. 73, 617–656 (2004).
  CAS PubMed Google Scholar
• Sawaya, M. R. et al. Atomic structures of amyloid cross-β spines reveal varied steric zippers. Nature 447, 453–457 (2007).
  CAS PubMed Google Scholar
• Vanik, D. L., Surewicz, K. A. & Surewicz, W. K. Molecular basis of barriers for interspecies transmissibility of mammalian prions. Mol. Cell 14, 139–145 (2004).
  CAS PubMed Google Scholar
• Nakayashiki, T., Ebihara, K., Bannai, H. & Nakamura, Y. Yeast [PSI+] “prions” that are crosstransmissible and susceptible beyond a species barrier through a quasi-prion state. Mol. Cell 7, 1121–1130 (2001).
  CAS PubMed Google Scholar
• Chen, B. et al. Genetic and epigenetic control of the efficiency and fidelity of cross-species prion transmission. Mol. Microbiol. 76, 1483–1499 (2010).
  CAS PubMed PubMed Central Google Scholar
• Edskes, H. K., McCann, L. M., Hebert, A. M. & Wickner, R. B. Prion variants and species barriers among Saccharomyces Ure2 proteins. Genetics 181, 1159–1167 (2009).
  CAS PubMed PubMed Central Google Scholar
• Kadnar, M. L., Articov, G. & Derkatch, I. L. Distinct type of transmission barrier revealed by study of multiple prion determinants of Rnq1. PLoS Genet. 6, e1000824 (2010). Despite the absence of amino acid substitutions, the authors uncover a prion transmission barrier between fragments of the Rnq1 prion [ RNQ+] of S. cerevisiae , suggesting that protein conformation is the key determinant in prion compatibility.
  PubMed PubMed Central Google Scholar
• Jones, E. M. & Surewicz, W. K. Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids. Cell 121, 63–72 (2005).
  CAS PubMed Google Scholar
• Tessier, P. M. & Lindquist, S. Unraveling infectious structures, strain variants and species barriers for the yeast prion [PSI+]. Nature Struct. Mol. Biol. 16, 598–605 (2009).
  CAS Google Scholar
• Pattison, I. H. & Jones, K. M. Modification of a strain of mouse-adapted scrapie by passage through rats. Res. Vet. Sci. 9, 408–410 (1968).
  CAS PubMed Google Scholar
• Kimberlin, R. H., Walker, C. A. & Fraser, H. The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in mice. J. Gen. Virol. 70, 2017–2025 (1989).
  PubMed Google Scholar
• Kimberlin, R. H., Cole, S. & Walker, C. A. Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. J. Gen. Virol. 68, 1875–1881 (1987).
  PubMed Google Scholar
• Makarava, N., Ostapchenko, V. G., Savtchenko, R. & Baskakov, I. V. Conformational switching within individual amyloid fibrils. J. Biol. Chem. 284, 14386–14395 (2009).
  CAS PubMed PubMed Central Google Scholar
• Si, K., Lindquist, S. & Kandel, E. R. A neuronal isoform of the Aplysia CPEB has prion-like properties. Cell 115, 879–891 (2003). By using expression in yeast, the authors provide the first evidence of the existence of a prion-based mechanism in the sensory neurons of Aplysia spp. (sea slug). In this case the translational regulator cytoplasmic polyadenylation element binding protein (CPEB) undergoes a conformational switch to a self-perpetuating amyloid that potentially affects synpatic efficiency and thus long-term facilitation.
  CAS PubMed Google Scholar
• Bernardi, G. Lessons from a small, dispensable genome: the mitochondrial genome of yeast. Gene 354, 189–200 (2005).
  CAS PubMed Google Scholar
• Ross, E. D., Edskes, H. K., Terry, M. J. & Wickner, R. B. Primary sequence independence for prion formation. Proc. Natl Acad. Sci. USA 102, 12825–12830 (2005).
  CAS PubMed PubMed Central Google Scholar
• Taneja, V., Maddelein, M. L., Talarek, N., Saupe, S. J. & Liebman, S. W. A non-Q/N-rich prion domain of a foreign prion, [Het-s], can propagate as a prion in yeast. Mol. Cell 27, 67–77 (2007).
  CAS PubMed PubMed Central Google Scholar